1. Kuhn TS (1970) The structure of scientific revolutions. International encyclopedia of unified science foundations of the unity of science, vol 2, no 2, 2nd edn. University of Chicago Press, Chicago
2. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER) (June 2012) Guidance for industry on: S2(R1) Genotoxicity testing and data interpretation for pharmaceuticals intended for human use. Available at:
https://www.fda.gov/downloads/drugs/-guidancecomplianceregulatoryinformation/guidances/ucm074931.pdf
3. Haasio K, Koponen A, Penttila KE, Nissinen E (2002) Effects of entacapone and tolcapone on mitochondrial membrane potential. Eur J Pharmacol 453(1):21–26
4. Yun GY, Kim SH, Kim SW, Joo JS, Kim JS, Lee ES, Lee BS, Kang SH, Moon HS, Sung JK, Lee HY, Kim KH (2016) Atypical onset of bicalutamide-induced liver injury. World J Gastroenterol 22(15):4062–4065.
https://doi.org/10.3748/wjg.v22.i15.4062
5. Greaves P, Williams A, Eve M (2004) First dose of potential new medicines to humans: how animals help. Nat Rev Drug Discov 3(3):226–236.
https://doi.org/10.1038/nrd1329